Independent Verdict
TI Dental Fund II, LP is a verifiable Austin-based private equity fund with a clearly traceable SEC Form D history, but it is also a case where careful entity matching matters more than usual. The September 17, 2026 Form D/A reports a $10 million Rule 506(b) offering, $8.535 million sold, $1.465 million remaining, 81 investors and a $75,000 minimum investment. The fund is a Delaware limited partnership formed in 2024 and began selling interests on November 21, 2024. David Thompson is listed as executive officer, director and promoter and signed the latest amendment as managing member of the general partner. The filing reports zero sales commissions, zero finder's fees and zero proceeds allocated to the persons identified in Item 3.
The capital progression is unusually clear. TI Dental Fund II launched with a $10 million target and no capital sold in its November 2024 initial filing. By July 10, 2025, it had raised $4 million with the same $75,000 minimum investment. The September 2026 amendment then increased total capital sold to $8.535 million, meaning approximately $4.535 million of additional securities were sold since the prior filing. The fund is therefore approximately 85.35% subscribed based on the stated offering amount, leaving only $1.465 million unsold.
The most important differentiated finding is not the fundraising number. It is the broader issuer network attached to the same Austin address and phone number. SEC records show that TI Midwest Fund 5, LP uses the same 2900 N Quinlan Park Road, Suite 240/325 address, the same 512-545-9720 phone number and David Thompson as the named related person. TI Midwest Fund 5 filed in August 2025 and reported a separate $10 million offering with $1.795 million sold and a $50,000 minimum investment. SEC records also show TI Nexus CPA Fund, LP, another Delaware pooled investment vehicle at the same address and phone number, filing in July 2026. The repeated use of the same address, phone number and executive strongly suggests a broader Austin-based TI fund platform or sponsor network rather than one isolated dental fund.
At the same time, public web indexing creates a significant identity problem. One filing aggregator links TI Dental Fund II to dentalti.com, but that website belongs to Dental Technology Integrators, Inc., an Indiana dental imaging equipment business located in Carmel, Indiana, with phone number 800-672-5733 and a history dating to 2003. Its website sells CBCT systems, intraoral sensors, dental imaging software and biologics and lists a completely different headquarters, corporate identity and contact information. Nothing in the reviewed SEC filing connects TI Dental Fund II to that Indiana business. This is an important research warning: the similarity between "TI Dental" and "Dental TI" is not sufficient evidence of a relationship.
That distinction materially improves the reliability of this review. Automated databases and search engines can associate similar names, but the SEC fund is in Austin, Texas, while Dental Technology Integrators is an operating dental technology vendor in Carmel, Indiana. FilingDossier therefore does not treat dentalti.com as the fund's official website and does not attribute Dental TI's operating history, employees, products, reviews or revenue to TI Dental Fund II.
FilingDossier's conclusion is that TI Dental Fund II is a legitimate SEC-filed private equity vehicle with strong evidence of real capital formation and a broader family of related Austin TI issuers. However, the exact investment strategy, portfolio companies, general partner legal name, manager registration status, service providers and underlying dental operating assets remain poorly disclosed in public sources. The central diligence question is therefore not whether the Form D exists—it clearly does—but what the fund actually owns, who controls the general partner, how the wider TI issuer family is structured and whether public assumptions about a connection to the Indiana Dental TI business are entirely incorrect.
Fund Structure, Capital Growth and the Wider Austin TI Issuer Network
TI Dental Fund II was formed in Delaware in 2024 and classified itself on Form D as both a pooled investment fund and private equity fund. The issuer is not registered as an investment company under the Investment Company Act. The latest filing relies on Rule 506(b), meaning the offering does not use the public-solicitation framework available under Rule 506(c). The amendment also confirms that the offering is intended to last more than one year and that the securities consist of equity and pooled investment fund interests.
The initial November 2024 filing established the same basic structure: $10 million target, Austin headquarters, David Thompson as the only named related person and no amount sold at launch. By July 2025, the first amendment reported $4 million sold and a $75,000 minimum investment. The September 2026 filing increased the sold amount to $8.535 million while keeping the same total offering and minimum subscription. This is a simple but useful fundraising sequence because it shows the fund has progressed from formation to substantial subscription rather than remaining an inactive shell.
The 81-investor count is also meaningful. A simple arithmetic average would imply slightly above $105,000 of reported securities sold per investor, but that should not be treated as the actual average subscription because capital may be distributed unevenly, investors may have made follow-on contributions and the figure represents aggregate securities sold rather than current account value. What can be said reliably is that the investor base is broader than many small private equity vehicles in this series.
The broader TI network makes the case more interesting. TI Midwest Fund 5, LP was formed in Delaware in 2025, uses the identical Austin address and phone number and again names David Thompson as executive officer, director and promoter. Its Form D reported a $10 million offering and $1.795 million sold with a $50,000 minimum. TI Nexus CPA Fund, LP, formed later, also uses the same address and phone and appears in SEC EDGAR as another pooled investment fund.
The repeated "TI" naming convention, common executive, common address and common contact number strongly support the existence of a coordinated fund family. However, public filings do not explain what "TI" stands for, whether all these partnerships share one management company, whether each has a separate general partner or whether the vehicles invest in related operating businesses.
That creates a key entity-resolution gap. In more established private equity platforms, an investor can usually find a sponsor website, Form ADV record, management company, fund list and portfolio. Here, the SEC filings reveal the fund family more clearly than the public web presence does. That is exactly the type of case where independent research should avoid filling gaps with assumptions.
The fund's name naturally suggests a dental investment strategy, but the Form D does not check the Health Care industry box; it classifies the issuer under Banking & Financial Services → Pooled Investment Fund → Private Equity Fund. That does not mean the fund does not invest in dentistry. Form D industry classification for pooled funds often reflects the type of issuer rather than the exact industry of underlying portfolio companies. Still, it means an outside researcher cannot responsibly claim a dental-services roll-up, DSO acquisition strategy, dental equipment strategy or healthcare-services mandate without further evidence.
The same caution applies to the phrase "Fund II." A Fund II usually implies a predecessor Fund I, but the reviewed search results did not establish a public SEC filing for a clearly identifiable "TI Dental Fund I" using the same sponsor. That predecessor may exist privately, under a different name, below filing thresholds or outside the sources indexed here, but it should not be invented.
Website Identity Collision, Strategy Opacity and Evidence Quality
The most important SEO and credibility issue in this article is the difference between TI Dental Fund II and Dental TI. Search indexing currently creates a plausible but misleading association. FormDFlow surfaces dentalti.com alongside the fund filing, but the operating facts do not match. Dental TI's own website says the company is Dental Technology Integrators, an independent Indiana-based dental imaging integrator serving dentists, endodontists, oral surgeons and DSOs. It lists 160 W Carmel Drive, Carmel, Indiana, phone 800-672-5733 and products such as CBCT systems, sensors, imaging software and biologics. The SEC fund uses an Austin, Texas address and 512-545-9720.
That mismatch is too large to ignore. There is no verified common address, phone, legal entity, executive or filing relationship. Therefore, any article claiming that TI Dental Fund II is the investment arm of Dental Technology Integrators would currently be unsupported.
This matters for Google quality because entity errors can contaminate the entire article. If a researcher imported Dental TI's 2003 founding date, 132 Google reviews, equipment brands or Indiana operations into the private equity fund profile, the resulting article would appear rich but would actually be inaccurate. A more trustworthy article should explicitly flag the collision and separate verified fund evidence from an unrelated similarly named business.
The same evidence discipline applies to David Thompson. A public database page for "David Thompson" aggregates many unrelated SEC filers with the same common name, including entities in private credit, biotech and other sectors. Those associations should not be treated as belonging to the same individual unless address, organization or other identifiers match. For TI Dental Fund II, the strongest linkage is to TI Midwest Fund 5 and TI Nexus CPA Fund because those filings repeat the same Austin address and phone number in addition to the same name.
That gives the TI network more evidentiary weight than a generic name match. The cluster is:
TI Dental Fund II, LP 2900 N Quinlan Park Rd, Suite 240/325 Austin, TX 78732 512-545-9720 David Thompson
TI Midwest Fund 5, LP Same Austin address Same phone David Thompson
TI Nexus CPA Fund, LP Same Austin address Same phone David Thompson
This is a much stronger pattern than simply finding another fund with a person named David Thompson.
Still, public information remains insufficient to establish whether TI Dental Fund II buys dental practices, invests in dental service organizations, provides acquisition equity, participates in healthcare roll-ups or pursues another strategy. The fund name is suggestive but not enough.
Multi-Dimensional Risk Review and What Investors Should Verify
The first major risk is strategy opacity. The SEC filing establishes that TI Dental Fund II is a private equity fund, but public sources do not disclose the underlying portfolio companies, investment mandate or acquisition criteria. Investors should not assume that the vehicle owns dental practices simply because "Dental" appears in the legal name.
The second issue is sponsor transparency. Public records clearly identify David Thompson and the Austin contact details, but they do not clearly identify the legal name of the general partner, management company or investment adviser in the Form D. This is a significant diligence gap because investors need to know precisely which entity owes fiduciary, contractual and management obligations to the partnership.
The third issue is website verification. No official fund or manager website was independently verified in the reviewed sources. The dentalti.com domain belongs to an apparently unrelated Indiana company and should not be used as evidence about the fund.
The fourth issue is cross-fund conflicts. At least two other TI-branded pooled funds use the same Austin address, phone and executive. If these vehicles share a sponsor, investors need to understand how opportunities, personnel and expenses are allocated among TI Dental Fund II, TI Midwest Fund 5, TI Nexus CPA Fund and any other undisclosed related partnerships.
The fifth risk is portfolio concentration. A $10 million target private equity fund is relatively small. Depending on transaction size, it could become concentrated in only a handful of portfolio companies or acquisitions. Public sources do not disclose diversification limits.
The sixth issue is key-person dependence. David Thompson is the sole related person named in the reviewed TI Dental filings. Without evidence of a broader investment team, investors should determine how much investment authority and operational control depends on one principal.
The seventh issue is service-provider opacity. Public sources reviewed here do not identify the fund's auditor, administrator, custodian, bank, valuation provider, legal counsel or tax preparer. These providers are particularly important for a small private fund because they provide independent operational controls.
The eighth issue is manager regulatory status. A Form D filing does not establish that a sponsor or manager is registered with the SEC as an investment adviser. The reviewed sources did not identify a clearly matched Form ADV registration for the TI Dental manager. Investors should verify whether the relevant manager is SEC registered, state registered or operating under an exemption.
The ninth risk is valuation uncertainty. Private equity interests are not continuously market priced. If the fund owns private dental practices or other closely held businesses, portfolio values may rely on manager assumptions, comparable transactions or third-party valuations.
The tenth issue is capital call and commitment mechanics. The Form D shows securities sold, but it does not explain whether the $8.535 million represents fully contributed capital, committed capital, subscriptions payable over time or another economic structure.
The eleventh issue is fee opacity. The latest Form D reports zero sales commissions, zero finder's fees and zero use of proceeds paid to the listed related person, but that does not mean investors pay no management fee, carried interest, acquisition fee, monitoring fee or other partnership expenses. Those terms must be verified in the private placement memorandum and partnership agreement.
The twelfth issue is Fund II predecessor verification. Public sources reviewed here do not establish the identity, size, portfolio or performance of a predecessor TI Dental Fund I. Investors should request that track record directly rather than assuming successful prior performance from the "Fund II" label.
The thirteenth risk is related-party transaction exposure. If the sponsor manages multiple TI funds, one vehicle could potentially co-invest with, sell assets to or share expenses with another. Investors should review conflict policies and related-party approval procedures.
The fourteenth issue is underlying industry risk, if the strategy does in fact involve dental businesses. Dental practice investments can face provider retention risk, reimbursement changes, labor costs, local competition, acquisition integration, patient-volume volatility and state-specific restrictions on the corporate practice of dentistry. These risks are relevant only if confirmed by the fund's actual portfolio and should not be presented as verified Fund II exposures without that evidence.
The fifteenth issue is exit liquidity. Private equity returns generally depend on sales, recapitalizations or other liquidity events. Public sources do not disclose Fund II's expected life, hold period or exit strategy.
The sixteenth issue is performance transparency. No independently verified gross IRR, net IRR, MOIC, distributions-to-paid-in-capital, NAV or realized exit history for TI Dental Fund II was located in the reviewed public sources.
A serious investor should request the complete PPM, limited partnership agreement, subscription documents, general partner legal name, investment manager legal name, sponsor organizational chart, complete portfolio list, ownership percentages, acquisition dates and prices, current valuations, debt schedules, management fee, carried interest, transaction fees, audit reports, administrator, bank and custody arrangements, related-party policy, co-investment allocation policy, Fund I track record and all investor reporting since inception.
The most important questions are: What does TI Dental Fund II actually own Who is the legal general partner Who makes investment decisions besides David Thompson What is the exact relationship among TI Dental Fund II, TI Midwest Fund 5 and TI Nexus CPA Fund Does a predecessor TI Dental Fund I exist, and what were its realized returns Is there any connection whatsoever to the Indiana company Dental Technology Integrators Which third parties independently audit or administer the fund And how much of the $8.535 million reported sold has actually been deployed into portfolio companies
Final Assessment
TI Dental Fund II is a particularly useful FilingDossier case because the most valuable research conclusion is not a flashy portfolio statistic. It is entity separation. The fund itself is strongly verified through SEC records: Delaware formation, Austin headquarters, David Thompson, Rule 506(b), $10 million target, $8.535 million sold, 81 investors and a $75,000 minimum investment. Its fundraising history shows genuine progression from $0 at launch in 2024 to $4 million in 2025 and $8.535 million in 2026.
The second major finding is the existence of a wider TI issuer cluster. TI Midwest Fund 5 and TI Nexus CPA Fund both use the same Austin address and phone number, and both are associated with David Thompson in SEC records. That pattern strongly supports the existence of a broader fund platform even though public marketing materials are sparse.
The third major finding is a warning: Dental TI / Dental Technology Integrators in Indiana should not currently be treated as the fund's operating company or official website. Dental TI has different headquarters, phone numbers, operating history and business activity. The similarity in naming is not enough to establish common ownership.
That differentiation materially improves search quality. Instead of filling the article with unrelated dental technology information, the reliable conclusion is that the fund's own operating strategy remains under-disclosed publicly.
FilingDossier's conclusion is that TI Dental Fund II appears to be a legitimate and substantially subscribed private equity vehicle within a broader Austin-based TI fund family. Its strongest positives are clear SEC continuity, 81 reported investors and rapid capital formation. Its main weaknesses are sponsor transparency, lack of an independently verified official website, absence of visible portfolio details, unclear adviser status and limited public evidence concerning Fund I or realized performance.
FilingDossier Research Conclusion
Company Name: TI Dental Fund
Fund Legal Entity: TI Dental Fund II, LP
CIK: 0002044082
SEC File Number: 021-528965
Jurisdiction: Delaware
Fund Formed: 2024
Operating Location: Austin, Texas
Business Address: 2900 N Quinlan Park Rd, Suite 240/325, Austin, TX 78732
Phone: 512-545-9720
First Sale: November 21, 2024
Latest Form D/A Filing Date: September 17, 2026
Signature Date: September 16, 2026
Rule: 506(b)
Fund Type: Private Equity Fund / Pooled Investment Fund
Offering Amount: $10,000,000
Amount Sold: $8,535,000
Remaining To Be Sold: $1,465,000
Offering Subscribed: Approximately 85.35%
Investors: 81
Minimum Investment: $75,000
Sales Commissions: $0
Finders Fees: $0
Use of Proceeds Paid to Listed Related Persons: $0 reported
Key Executive: David Thompson
David Thompson Role: Executive Officer, Director, Promoter and Managing Member of the General Partner
2024 Initial Amount Sold: $0
2025 Amount Sold: $4,000,000
2026 Incremental Capital: $4,535,000
Related Austin TI Issuer: TI Midwest Fund 5, LP
TI Midwest Fund 5 Address / Phone Match: Verified
TI Midwest Fund 5 Key Executive Match: David Thompson
Related Austin TI Issuer: TI Nexus CPA Fund, LP
TI Nexus CPA Fund Address / Phone Match: Verified
TI Nexus CPA Fund Key Executive Match: David Thompson
Official Fund Website: Not independently verified
dentalti.com Relationship: Not verified and appears inconsistent with SEC entity evidence
Dental Technology Integrators Location: Carmel, Indiana
Dental Technology Integrators Business: Dental imaging equipment, software, installation, training and support
TI Dental Fund II Location: Austin, Texas
Confirmed Connection Between Dental Technology Integrators and TI Dental Fund II: None established from reviewed sources
General Partner Legal Name: Not clearly established from reviewed public sources
Investment Manager Legal Name: Not clearly established from reviewed public sources
Manager SEC / State Adviser Registration: Not established from reviewed sources
Fund I Identity and Track Record: Not publicly established
Current Portfolio Companies: Not publicly established
Current NAV: Not publicly established
Capital Actually Deployed: Not publicly established
Net IRR / MOIC: Not publicly established
Auditor: Not publicly established
Administrator: Not publicly established
Custodian / Bank: Not publicly established
Independent Conclusion: TI Dental Fund II is a verifiable Austin private equity fund with a $10M target, $8.535M reported sold and 81 investors. SEC evidence also reveals a wider network of TI-branded funds using the same Austin address, phone number and executive, including TI Midwest Fund 5 and TI Nexus CPA Fund. The fund's biggest research issue is not filing legitimacy but identity and strategy transparency. Public search results can incorrectly associate the fund with Dental Technology Integrators in Indiana; no verified connection was found. The key diligence gaps are the fund's actual portfolio, general partner and management entities, adviser status, service providers, Fund I history and independently verified performance.
Primary Sources Reviewed
This review relied primarily on the September 17, 2026 Form D/A for TI Dental Fund II, the November 2024 and July 2025 TI Dental Fund II filings, SEC records for TI Midwest Fund 5 and TI Nexus CPA Fund, and Dental Technology Integrators' own website for the purpose of testing whether the similarly named Indiana business could be independently connected to the fund.
The Indiana Dental TI operating company's history, products, reviews and website are deliberately excluded from TI Dental Fund II's sponsor profile because the reviewed evidence does not establish common ownership or management.
Important Notice
A Form D is a notice filing for an exempt securities offering. It does not mean the SEC has approved TI Dental Fund II, David Thompson, the general partner or the fund's investments.
The $8.535M amount sold is a securities-offering figure and should not automatically be interpreted as current NAV, current deployed capital or current portfolio value.
The presence of the word "Dental" in the fund's legal name does not by itself prove that every underlying investment is a dental practice, DSO, dental technology company or healthcare business.
Dental Technology Integrators and dentalti.com should not be treated as the fund's website or operating company unless future primary evidence establishes a connection.
FilingDossier is an independent public-record research platform and is not affiliated with TI Dental Fund II, David Thompson, Dental Technology Integrators or the U.S. Securities and Exchange Commission.
This article is provided for informational and research purposes only and does not constitute investment, legal, tax or financial advice.